Penn Medicine, IBA form joint venture to guide proton therapy programs
LOUVAIN-LA-NEUVE: Penn Medicine and IBA announced Monday the creation of Noventra Oncology Alliance, a joint venture aimed at helping health care providers develop, implement and operate proton therapy and advanced radiation oncology programs. The new company will offer integrated services…